Palouse Capital Management, Inc. has filed its 13F form on August 12, 2024 for Q2 2024 where it was disclosed a total value porftolio of $146 Million distributed in 117 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Microsoft Corp with a value of $5.25M, Spdr Bloomberg 1 3 Month T Bil with a value of $4.96M, Pfizer Inc with a value of $4.18M, Vanguard Intermediate Term Cor with a value of $4.17M, and Tyson Foods, Inc. with a value of $4.16M.

Examining the 13F form we can see an decrease of $3.18M in the current position value, from $149M to 146M.

Below you can find more details about Palouse Capital Management, Inc. portfolio as well as his latest detailed transactions.

Portfolio value $146 Million
Technology: $27.4 Million
ETFs: $18 Million
Financial Services: $17.7 Million
Consumer Defensive: $17.3 Million
Healthcare: $14 Million
Communication Services: $11.6 Million
Consumer Cyclical: $11.5 Million
Energy: $11.1 Million
Other: $17.6 Million

Stock Holdings Table Market Cap. of $50 Millions to $300 Millions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 117
  • Current Value $146 Million
  • Prior Value $149 Million
  • Filing
  • Period Q2 2024
  • Filing Date August 12, 2024
  • Form Type 13F-HR
  • Activity in Q2 2024
  • New Purchases 11 stocks
  • Additional Purchases 19 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 71 stocks
Track This Portfolio

Track Palouse Capital Management, Inc. Portfolio

Follow Palouse Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Palouse Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Palouse Capital Management, Inc. with notifications on news.